Seattle-based information services company Navigating Cancer has secured $26 million in Series D funding, according to company database Crunchbase, topping the city’s recent funding headlines. The cash infusion was announced September 17 and led by Merck Global Health Innovation Fund.
According to its Crunchbase profile, "Navigating Cancer, Inc. owns and operates a website for cancer patients and their supporters that allow them to read about the disease, discuss ailments with others, organize personal health records and track medications/treatments. The company was founded in 2008 and is based in Seattle, Washington. Navigating Cancer’s mission is to transform healthcare through patient-centered care by using technology to connect every cancer patient to their healthcare team, their own health records and the right information at the right time."
The 12-year-old company has raised five previous funding rounds, including a $12 million round earlier this year.
The round brings total funding raised by Seattle companies in health care over the past month to $31 million, an increase of $25 million from the month before. The local health care industry has seen 44 funding rounds over the past year, raking in a total of $393 million in venture funding.
In other local funding news, construction company Unearth announced a $7 million Series A funding round on September 16.
According to Crunchbase, "Your solution helped us get paid more, faster by creating accurate measurements and reducing communication time with field personnel and subcontractors. Thank you"
Founded in 2016, the company has raised two previous rounds, including a $3 million round in 2018.
This story was created automatically using local investment data, then reviewed by an editor. Click here for more about what we're doing. Got thoughts? Go here to share your feedback.
